Implicity has announced a distribution agreement with MicroPort CRM, through which MicroPort CRM can sell and distribute Implicity’s cloud-based solution in the USA as part of its remote patient monitoring offerings with a new digital service that allows cardiologists and electrophysiologists to seamlessly manage data being collected by various cardiac implantable electronic devices (CIEDs).
“We are excited to partner with Implicity and their cloud-based remote monitoring platform, which creates a more efficient and comprehensive workflow for healthcare providers to manage patients with CIEDs. Our teams have worked closely to better integrate MicroPort’s CIED data into Implicity’s platform, enabling Implicity to be the best suited third-party platform for our customers when it comes to the remote monitoring of MicroPort CIED implants,” said Aamir Mahmood, vice president, MicroPort Americas.
Implicity provides a cloud-based and AI-driven universal cardiac remote monitoring platform that aggregates data from CIEDs across all manufacturers (MicroPort, Medtronic, Abbott, Biotronik and Boston Scientific) and manages the entire clinical and administrative workflow thus enabling medical centres to scale their cardiac remote monitoring practices.
The solution also integrates patient clinical data from the electronic health record (EHR) systems and other sources. The combined information is then automatically analysed by the technology to determine true high priority events.
“We are thrilled to collaborate with MicroPort CRM. This distribution partnership will help us reach out to fast growing number of healthcare providers that need to scale their cardiac remote monitoring practices, cope with the data tsunami from cardiac implants and improve patient outcome,” said Arnaud Rosier, electrophysiologist, CEO and founder of Implicity.